CXCR3-B Can Mediate Growth-inhibitory Signals in Human Renal Cancer Cells by Down-regulating the Expression of Heme Oxygenase-1
Authors:
Open Access
- 1 November 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (47) , 36842-36848
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A Novel Experimental Heme Oxygenase-1–Targeted Therapy for Hormone-Refractory Prostate CancerCancer Research, 2009
- Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and diseaseFree Radical Biology and Medicine, 2009
- Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer ProgressionJournal of the American Society of Nephrology, 2008
- Heme Oxygenase-1 in Tumors: Is It a False Friend?Antioxidants & Redox Signaling, 2007
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJournal of Experimental Medicine, 2006
- Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissuesKidney International, 2006
- CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine productionJournal of Allergy and Clinical Immunology, 2005
- The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- CXC chemokines in angiogenesis of cancerSeminars in Cancer Biology, 2004
- Chemokines in neoplastic progressionSeminars in Cancer Biology, 2004